Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
23-26 March, 2026
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Not Confirmed
Not Confirmed
12-14 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
23-26 March, 2026
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Industry Trade Show
Not Confirmed
12-14 January, 2026
Digital content

16 Dec 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251216955463/en/Vir-Biotechnology-Grants-Norgine-Exclusive-Commercial-License-to-Chronic-Hepatitis-Delta-Treatment-Candidate-in-Europe-Australia-New-Zealand-Including-Global-Cost-Sharing-Agreement-for-Ongoing-ECLIPSE-Clinical-Development-Program

19 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251119534043/en/Vir-Biotechnology-to-Participate-in-the-8th-Annual-Evercore-Healthcare-Conference

09 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251108769432/en/Vir-Biotechnology-Announces-AASLD-The-Liver-Meeting-Presentation-New-England-Journal-of-Medicine-Publication-of-Phase-2-Data-Demonstrating-Tobevibart-Elebsiran-Combination-Deliver-High-Rates-of-Undetectable-HDV-RNA-with-Favorable-Safety-Profile

07 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251107857542/en/Vir-Biotechnology-to-Participate-in-the-Jefferies-2025-London-Healthcare-Conference

05 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251105955316/en/Vir-Biotechnology-Provides-Corporate-Update-and-Reports-Third-Quarter-2025-Financial-Results

03 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251103530329/en/Vir-Biotechnology-Announces-Completion-of-Enrollment-in-ECLIPSE-1-Phase-3-Trial-for-Chronic-Hepatitis-Delta
ABOUT THIS PAGE